Annual Drug Patent Expirations for REMODULIN Remodulin is a drug marketed by United Therap and is included in two NDAs. It is available from one supplier. There are ten patents…
The post New patent for United Therap drug REMODULIN appeared first on Dru…
Annual Drug Patent Expirations for OFEV Ofev is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are five patents…
The post New patent for Boehringer Ingelheim drug OFEV appeared first on Drug…
This chart shows the pharmaceutical companies with the most patents in Netherlands. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug …
Which pharmaceutical companies have the most drug patents in Netherlands? Read Post »
Over the past two decades, Bayer Pharma has developed an in silico absorption, distribution, metabolism, and excretion (ADMET) platform with the aim of generating models for various pharmacokinetic and physicochemical…
The post Advancements in In Silic…
Over the past two decades, Bayer Pharma has developed an in silico absorption, distribution, metabolism, and excretion (ADMET) platform with the aim of generating models for various pharmacokinetic and physicochemical…
The post Advancements in In Silic…
This chart shows the drugs with the most patents in Lithuania. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Lithu…
Which pharmaceutical drugs have the most drug patents in Lithuania? Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Spain. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical c…
Which pharmaceutical companies have the most SPCs in Spain? Read Post »
Annual Drug Patent Expirations for BOSULIF Bosulif is a drug marketed by Pf Prism Cv and is included in one NDA. It is available from two suppliers. There are five…
The post New patent for Pf Prism drug BOSULIF appeared first on DrugPatentWatch – Make …
Annual Drug Patent Expirations for LUPKYNIS Lupkynis is a drug marketed by Aurinia and is included in one NDA. It is available from one supplier. There are three patents protecting…
The post New patent for Aurinia drug LUPKYNIS appeared first on DrugPa…
Annual Drug Patent Expirations for FIRMAGON Firmagon is a drug marketed by Ferring and is included in one NDA. It is available from one supplier. There are five patents protecting…
The post New patent for Ferring drug FIRMAGON appeared first on DrugPat…
Get new actionable insights and updates from BiotechBlog
